Document is current
Any future updates will be listed below
-
Authors
Xu, Yang
Hashimoto, Noboru
Kano, Fumiya
Xia, Linze
Ding, Cheng
Lao, Houjun
Wang, Yifei
Arai, Takahiro
Iwasaki, Tomonori
Yamamoto, Akihito
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 6 October 2025
First Online: 31 October 2025
Declarations
:
: The experiments involving human materials were approved by the Institutional Ethical Committee of Tokushima University Hospital and conducted according to the principles of the Declaration of Helsinki (Project No: 3268). Informed consent was obtained from the parents or guardians of the patients. Participation in the study was voluntary, and no compensation was provided to the donors. The animal study protocol was approved by the Animal Research Committee of Tokushima University under the project titled, “Development of a novel therapeutic agents for atopic dermatitis” (Permit No: T2022-54; Date of Permit: August 10, 2022). The animal study was performed in line with ARRIVE guidelines 2.0.
: Not applicable.
: The authors declare no competing interests.
